TerrAscend (TSNDF) Gains from Sales and Divestitures (2020 - 2026)
TerrAscend (TSNDF) reported Gains from Sales and Divestitures of $10143.0 for Q1 2026, down 83.8% year-over-year from $62593.0 in Q1 2025, and down 99.73% quarter-over-quarter from $3.8 million in Q4 2025.
TerrAscend (TSNDF) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Gains from Sales and Divestitures data on file, last reported at $10143.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $10143.0, down 83.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $10143.0 (down 83.8% YoY), and the FY2025 annual result was $3.8 million, up 139.71% from the prior year.
- Gains from Sales and Divestitures eased to $10143.0 in Q1 2026 per TSNDF's latest filing, from $3.8 million in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $3.8 million in Q4 2025 and troughed at $10143.0 in Q1 2026.
- A 5-year average of $546734.4 and a median of $165833.0 in 2022 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2026: Gains from Sales and Divestitures soared 1546.32% in 2022, then slumped 83.8% in 2026.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $669478.0 in 2022, then slipped by 10.05% to $602183.0 in 2023, then surged by 162.71% to $1.6 million in 2024, then surged by 139.71% to $3.8 million in 2025, then sank by 99.73% to $10143.0 in 2026.
- Business Quant data shows TSNDF's Gains from Sales and Divestitures at $10143.0 in Q1 2026, $3.8 million in Q4 2025, and $668006.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,143.00 |
| Mar 31, 2026 | 10,143.00 |
| Dec 31, 2025 | 3.79 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 668,006.00 |
| Sep 30, 2025 | 668,006.00 |
| Jun 30, 2025 | 542,087.00 |
| Jun 30, 2025 | 542,087.00 |
| Mar 31, 2025 | 62,593.00 |
| Mar 31, 2025 | 62,593.00 |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 342,510.00 |
| Sep 30, 2024 | 342,510.00 |
| Jun 30, 2024 | 336,037.00 |
| Jun 30, 2024 | 336,037.00 |
| Mar 31, 2024 | 82,365.00 |
| Mar 31, 2024 | 82,365.00 |
| Dec 31, 2023 | 602,183.00 |
| Dec 31, 2023 | 602,183.00 |